# Cellectis S.A. (CLLS)

> Healthcare · FR · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/CLLS/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 11.02M | $ -39.62M | $ -30.36M | $ 84.57M | $ 41.07M |
| 2025 | $ 74.69M | $ -69.21M | $ -42.88M | $ 119.90M | $ 75.90M |
| 2024 | $ 43.63M | $ -38.64M | $ 20.12M | $ 91.46M | $ 131.03M |
| 2023 | $ 819.4K | $ -110.94M | $ -27.92M | $ 85.06M | $ 84.70M |
| 2022 | $ 21.58M | $ -118.83M | $ -99.92M | $ 75.77M | $ 117.97M |
| 2021 | $ 68.10M | $ -135.74M | $ -147.76M | $ 100.87M | $ 221.29M |
| 2020 | $ 93.15M | $ -104.39M | $ -161.18M | $ 106.68M | $ 283.80M |
| 2019 | $ 19.50M | $ -131.76M | $ -105.97M | $ 47.61M | $ 315.12M |
| 2018 | $ 17.12M | $ -103.77M | $ -96.44M | $ 1.35M | $ 409.30M |
| 2017 | $ 34.16M | $ -135.68M | $ -74.07M | $ 34.0K | $ 266.79M |
| 2016 | $ 61.67M | $ -92.99M | $ -61.12M | $ 1.76M | $ 272.18M |
| 2015 | $ 77.79M | $ -31.79M | $ -1.14M | $ 2.17M | $ 287.42M |
| 2014 | $ 48.20M | $ 4.08M | $ 71.12M | $ 4.48M | $ 73.92M |
| 2013 | $ 24.16M | $ -48.57M | $ -36.40M | $ 5.61M | $ 6.95M |
| 2012 | $ 16.59M | $ -17.38M | $ -16.23M | $ 5.67M | $ 78.93M |
| 2011 | N/A | N/A | N/A | $ 69.08M | $ 37.02M |
| 2010 | N/A | N/A | N/A | $ 1.82M | $ 50.13M |
| 2009 | N/A | N/A | N/A | $ 2.62M | $ 73.22M |
| 2008 | N/A | N/A | N/A | $ 1.82M | $ 46.21M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 2.06 |
| Liabilities / Eq | 5.51 |
| Current Ratio | 1.37 |

## Other views

- [Metrics](https://sponda.capital/en/CLLS.md)
- [Charts](https://sponda.capital/en/CLLS/charts.md)
- [Compare](https://sponda.capital/en/CLLS/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.
